MLEC Overview

Moolec Science SA is a science-based food ingredient company. The Company operates an integrated platform encompassing research & development (R&D), manufacturing, and regulatory capabilities that span from molecular design to validation in both fermenter and field environments. It operates across the United States, Europe, and South America. The Company advances its molecular farming programs in crops such as soy and safflower to produce proteins and lipids with animal-like functionality and plant-based cost structures. It is developing a precision fermentation facility in Finland, under the SynBio Powerlabs brand, which will be dedicated to producing target proteins, enzymes, and other biomolecules using optimized microbial and cellular systems. Its product portfolio includes GLASO, PIGGY SOOY, VALORASOY, and MYCOFOOD. Its GLASO, a safflower-derived oil rich in functional lipids, is being used in formulations for small-animal feed.

Wall Street analysts forecast MLEC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLEC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Moolec Science SA revenue for the last quarter amounts to 2.64M USD, increased 948.32

Moolec Science SA. EPS for the last quarter amounts to -9.35 USD, increased 32.06

Moolec Science SA (MLEC) has 52 emplpoyees as of March 31 2026.

Today MLEC has the market capitalization of 4.30M USD.